{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:24:11Z","timestamp":1793651051581,"version":"4.5.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["#0018\/DIA\/2019\/48"],"award-info":[{"award-number":["#0018\/DIA\/2019\/48"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024109","name":"Uniwersytet Gda\u0144ski","doi-asserted-by":"publisher","award":["#531-T040-D838-25"],"award-info":[{"award-number":["#531-T040-D838-25"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["503\/1-156-04\/503-11-001"],"award-info":[{"award-number":["503\/1-156-04\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s43440-025-00790-x","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:19:52Z","timestamp":1760498392000},"page":"1689-1702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthesis and evaluation of KR-12, an LL-37 fragment, and its short-chain fatty acid derivatives: selective cytotoxicity in colorectal cancer cells and anti-tumor efficacy in an azoxymethane\/DSS-induced colitis-associated cancer mouse model"],"prefix":"10.1007","volume":"77","author":[{"given":"Jakub","family":"W\u0142odarczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Kamysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"790_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"key":"790_CR2","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/J.TRANON.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. https:\/\/doi.org\/10.1016\/J.TRANON.2021.101174.","journal-title":"Transl Oncol"},{"key":"790_CR3","doi-asserted-by":"publisher","unstructured":"Adebayo AS, Agbaje K, Adesina SK, Olajubutu O. Colorectal cancer: disease process, current treatment options, and future perspectives. Pharmaceutics 2023;15. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15112620","DOI":"10.3390\/PHARMACEUTICS15112620"},{"key":"790_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.20517\/CDR.2022.136","volume":"6","author":"WH Gmeiner","year":"2023","unstructured":"Gmeiner WH, Okechukwu CC. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist. 2023;6:257. https:\/\/doi.org\/10.20517\/CDR.2022.136.","journal-title":"Cancer Drug Resist"},{"key":"790_CR5","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1007\/S11033-012-1997-X","volume":"39","author":"EM Ko\u015bciuczuk","year":"2012","unstructured":"Ko\u015bciuczuk EM, Lisowski P, Jarczak J, Strza\u0142kowska N, J\u00f3\u017awik A, Horba\u0144czuk J, et al. Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep. 2012;39:10957. https:\/\/doi.org\/10.1007\/S11033-012-1997-X.","journal-title":"Mol Biol Rep"},{"key":"790_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/J.1432-1033.1996.0325Z.X","volume":"238","author":"GH Gudmundsson","year":"1996","unstructured":"Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the Cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem. 1996;238:325\u201332. https:\/\/doi.org\/10.1111\/J.1432-1033.1996.0325Z.X.","journal-title":"Eur J Biochem"},{"key":"790_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5114\/CEJI.2018.81355","volume":"43","author":"K Majewski","year":"2018","unstructured":"Majewski K, Koz\u0142owska E, \u017belechowska P, Brzezi\u0144ska-B\u0142aszczyk E. Serum concentrations of antimicrobial peptide Cathelicidin LL-37 in patients with bacterial lung infections. Cent Eur J Immunol. 2018;43:453\u20137. https:\/\/doi.org\/10.5114\/CEJI.2018.81355.","journal-title":"Cent Eur J Immunol"},{"key":"790_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1684\/EJD.2008.0304","volume":"18","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Gallo RL. Antimicrobial peptides in human skin disease. Eur J Dermatol. 2007;18:11. https:\/\/doi.org\/10.1684\/EJD.2008.0304.","journal-title":"Eur J Dermatol"},{"key":"790_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-00816-w","volume":"8","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhen J, Zhang R, Wanyan Y, Liu K, Yuan X, et al. Cathelicidin hCAP18\/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)2D3 in hepatocellular carcinoma. Cell Death Discovery 2022. 2022;8:1. https:\/\/doi.org\/10.1038\/s41420-022-00816-w.","journal-title":"Cell Death Discovery 2022"},{"key":"790_CR10","doi-asserted-by":"publisher","first-page":"8349712","DOI":"10.1155\/2020\/8349712","volume":"2020","author":"B Yang","year":"2020","unstructured":"Yang B, Good D, Mosaiab T, Liu W, Ni G, Kaur J, et al. Significance of LL-37 on Immunomodulation and disease outcome. Biomed Res Int. 2020;2020:8349712. https:\/\/doi.org\/10.1155\/2020\/8349712.","journal-title":"Biomed Res Int"},{"key":"790_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/S00005-015-0359-5","volume":"64","author":"E Piktel","year":"2015","unstructured":"Piktel E, Niemirowicz K, Wnorowska U, W\u0105tek M, Wollny T, G\u0142uszek K, et al. The role of Cathelicidin LL-37 in cancer development. Arch Immunol Ther Exp (Warsz). 2015;64:33. https:\/\/doi.org\/10.1007\/S00005-015-0359-5.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"790_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ejmech.2017.05.028","volume":"136","author":"EY Kim","year":"2017","unstructured":"Kim EY, Rajasekaran G, Shin SY. LL-37-derived short antimicrobial peptide KR-12-a5 and its D-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity. Eur J Med Chem. 2017;136:428\u201341. https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.028.","journal-title":"Eur J Med Chem"},{"key":"790_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5551\/jat.RV17006","volume":"24","author":"H Ohira","year":"2017","unstructured":"Ohira H, Tsutsui W, Fujioka Y. Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb. 2017;24:660\u201372. https:\/\/doi.org\/10.5551\/jat.RV17006.","journal-title":"J Atheroscler Thromb"},{"key":"790_CR14","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1136\/gut.35.1_Suppl.S35","volume":"35","author":"W Scheppach","year":"1994","unstructured":"Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35:S35\u20138.","journal-title":"Gut"},{"key":"790_CR15","doi-asserted-by":"publisher","first-page":"101810","DOI":"10.1016\/J.CPSURG.2025.101810","volume":"69","author":"J W\u0142odarczyk","year":"2025","unstructured":"W\u0142odarczyk J, Dziki \u0141, Harmon J, Fichna J. The role of short-chain fatty acids in the prehabilitation before colorectal surgery. Curr Probl Surg. 2025;69:101810. https:\/\/doi.org\/10.1016\/J.CPSURG.2025.101810.","journal-title":"Curr Probl Surg"},{"key":"790_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite Butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128\u201339. https:\/\/doi.org\/10.1016\/j.immuni.2013.12.007.","journal-title":"Immunity"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","volume":"69","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, et al. GPR109A is a G-protein-Coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69:2826\u201332. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4466.","journal-title":"Cancer Res"},{"key":"790_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/gut.52.5.735","volume":"52","author":"J Schauber","year":"2003","unstructured":"Schauber J, Svanholm C, Term\u00e9n S, Iffland K, Menzel T, Scheppach W, et al. Expression of the Cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut. 2003;52:735\u201341.","journal-title":"Gut"},{"key":"790_CR19","doi-asserted-by":"publisher","unstructured":"Kamysz E, Sikorska E, Ja\u015bkiewicz M, Bauer M, Neubauer D, Bartoszewska S, et al. Lipidated analogs of the LL-37-Derived peptide fragment KR12-Structural Analysis, Surface-Active properties and antimicrobial activity. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/IJMS21030887.","DOI":"10.3390\/IJMS21030887"},{"key":"790_CR20","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/J.YEXMP.2024.104938","volume":"140","author":"M Remke","year":"2024","unstructured":"Remke M, Groll T, Metzler T, Urbauer E, K\u00f6vilein J, Schnalzger T, et al. Histomorphological scoring of murine colitis models: A practical guide for the evaluation of colitis and colitis-associated cancer. Exp Mol Pathol. 2024;140:104938. https:\/\/doi.org\/10.1016\/J.YEXMP.2024.104938.","journal-title":"Exp Mol Pathol"},{"key":"790_CR21","doi-asserted-by":"publisher","unstructured":"Keshri AK, Rawat SS, Chaudhary A, Sharma S, Kapoor A, Mehra P et al. LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity. Int J Antimicrob Agents 2025;65. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2024.107398","DOI":"10.1016\/J.IJANTIMICAG.2024.107398"},{"key":"790_CR22","doi-asserted-by":"publisher","unstructured":"Lu F, Zhu Y, Zhang G, Liu Z. Renovation as innovation: repurposing human antibacterial peptide LL-37 for cancer therapy. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/FPHAR.2022.944147.","DOI":"10.3389\/FPHAR.2022.944147"},{"key":"790_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.18388\/PB.2021_396","volume":"67","author":"J W\u0142odarczyk","year":"2021","unstructured":"W\u0142odarczyk J, P\u0142oska M, P\u0142oski K, Fichna J. [The role of short-chain fatty acids in inflammatory bowel diseases and colorectal cancer]. Postepy Biochem. 2021;67:223\u201330. https:\/\/doi.org\/10.18388\/PB.2021_396.","journal-title":"Postepy Biochem"},{"key":"790_CR24","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.3390\/IJMS24065505\/S1","volume":"24","author":"E Kamysz","year":"2023","unstructured":"Kamysz E, Sikorska E, Bauer M, Sikora K, Neubauer D. Influence of lipidation pattern of the KR12 fragment of peptide LL-37 on its antibacterial and hemolytic activities. Int J Mol Sci. 2023;24:5505. https:\/\/doi.org\/10.3390\/IJMS24065505\/S1.","journal-title":"Int J Mol Sci"},{"key":"790_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/S43440-020-00190-3","volume":"73","author":"N Fabisiak","year":"2021","unstructured":"Fabisiak N, Fabisiak A, Chmielowiec-Korzeniowska A, Tymczyna L, Kamysz W, Kordek R, et al. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases. Pharmacol Rep. 2021;73:163\u201371. https:\/\/doi.org\/10.1007\/S43440-020-00190-3","journal-title":"Pharmacol Rep"},{"key":"790_CR26","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-12-2359","volume":"72","author":"SX Ren","year":"2012","unstructured":"Ren SX, Cheng ASL, To KF, Tong JHM, Li MS, Shen J, et al. Host immune defense peptide LL-37 activates Caspase-Independent apoptosis and suppresses colon cancer. Cancer Res. 2012;72:6512\u201323. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2359.","journal-title":"Cancer Res"},{"key":"790_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0063641","volume":"8","author":"SX Ren","year":"2013","unstructured":"Ren SX, Shen J, Cheng ASL, Lu L, Chan RLY, Li ZJ, et al. FK-16 derived from the anticancer peptide LL-37 induces Caspase-Independent apoptosis and autophagic cell death in colon cancer cells. PLoS ONE. 2013;8:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0063641.","journal-title":"PLoS ONE"},{"key":"790_CR28","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3892\/ijo.2015.2887","volume":"46","author":"K KURODA","year":"2015","unstructured":"Kuroda K, Fukuda T, Isogai H, Okumura K, Krstic-Demonacos M Isogaie. Antimicrobial peptide FF\/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile. Int J Oncol. 2015;46:1516\u201326. https:\/\/doi.org\/10.3892\/ijo.2015.2887","journal-title":"Int J Oncol"},{"key":"790_CR29","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-12-2359","volume":"72","author":"SX Ren","year":"2012","unstructured":"Ren SX, Cheng ASL, To KF, Tong JHM, Li MS, Shen J, et al. Host immune defense peptide LL-37 activates Caspase-Independent apoptosis and suppresses colon cancer. Cancer Res. 2012;72:6512. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2359.","journal-title":"Cancer Res"},{"key":"790_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1615\/CRITREVIMMUNOL.2019030225","volume":"39","author":"M Zhang","year":"2019","unstructured":"Zhang M, Liang W, Gong W, Yoshimura T, Chen K, Wang JM. The critical role of the antimicrobial peptide LL-37\/CRAMP in protection of colon microbiota Balance, mucosal Homeostasis, Anti-Inflammatory Responses, and resistance to carcinogenesis. Crit Rev Immunol. 2019;39:83. https:\/\/doi.org\/10.1615\/CRITREVIMMUNOL.2019030225.","journal-title":"Crit Rev Immunol"},{"key":"790_CR31","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.4049\/JIMMUNOL.1602073","volume":"200","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, et al. The antimicrobial peptide CRAMP is essential for colon homeostasis by maintaining microbiota balance. J Immunol. 2018;200:2174\u201385. https:\/\/doi.org\/10.4049\/JIMMUNOL.1602073.","journal-title":"J Immunol"},{"key":"790_CR32","doi-asserted-by":"publisher","unstructured":"Borowczak J, Szczerbowski K, Maniewski M, Kowalewski A, Janiczek-Polewska M, Szylberg A et al. The role of inflammatory cytokines in the pathogenesis of colorectal carcinoma\u2014recent findings and review. Biomedicines 2022, Vol 10, Page 1670. 2022;10:1670. https:\/\/doi.org\/10.3390\/BIOMEDICINES10071670","DOI":"10.3390\/BIOMEDICINES10071670"},{"key":"790_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-11-87\/FIGURES\/7","volume":"11","author":"Y Li","year":"2012","unstructured":"Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer. 2012;11:1\u201313. https:\/\/doi.org\/10.1186\/1476-4598-11-87\/FIGURES\/7.","journal-title":"Mol Cancer"},{"key":"790_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00384-024-04748-Y\/TABLES\/4","volume":"39","author":"VK Shahgoli","year":"2024","unstructured":"Shahgoli VK, Noorolyai S, Ahmadpour Youshanlui M, Saeidi H, Nasiri H, Mansoori B, et al. Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link. Int J Colorectal Dis. 2024;39:1\u201315. https:\/\/doi.org\/10.1007\/S00384-024-04748-Y\/TABLES\/4.","journal-title":"Int J Colorectal Dis"},{"key":"790_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3389\/FIMMU.2020.01137","volume":"11","author":"MR Scheenstra","year":"2020","unstructured":"Scheenstra MR, van Harten RM, Veldhuizen EJA, Haagsman HP, Coorens M. Cathelicidins modulate TLR-Activation and inflammation. Front Immunol. 2020;11:1137. https:\/\/doi.org\/10.3389\/FIMMU.2020.01137.","journal-title":"Front Immunol"},{"key":"790_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000335901","volume":"4","author":"A Nijnik","year":"2012","unstructured":"Nijnik A, Pistolic J, Filewod NCJ, Hancock REW. Signaling pathways mediating chemokine induction in keratinocytes by Cathelicidin LL-37 and Flagellin. J Innate Immun. 2012;4:377\u201386. https:\/\/doi.org\/10.1159\/000335901.","journal-title":"J Innate Immun"},{"key":"790_CR37","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.4049\/JIMMUNOL.0901491","volume":"183","author":"A Nijnik","year":"2009","unstructured":"Nijnik A, Pistolic J, Wyatt A, Tam S, Hancock REW. Human Cathelicidin peptide LL-37 modulates the effects of IFN-gamma on apcs. J Immunol. 2009;183:5788\u201398. https:\/\/doi.org\/10.4049\/JIMMUNOL.0901491.","journal-title":"J Immunol"},{"key":"790_CR38","doi-asserted-by":"publisher","first-page":"e85765","DOI":"10.1371\/JOURNAL.PONE.0085765","volume":"9","author":"Z Hu","year":"2014","unstructured":"Hu Z, Murakami T, Suzuki K, Tamura H, Kuwahara-Arai K, Iba T, et al. Antimicrobial Cathelicidin peptide LL-37 inhibits the LPS\/ATP-Induced pyroptosis of macrophages by dual mechanism. PLoS ONE. 2014;9:e85765. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0085765.","journal-title":"PLoS ONE"},{"key":"790_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/INTIMM\/DXV113","volume":"28","author":"Z Hu","year":"2016","unstructured":"Hu Z, Murakami T, Suzuki K, Tamura H, Reich J, Kuwahara-Arai K, et al. Antimicrobial Cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. Int Immunol. 2016;28:245\u201353. https:\/\/doi.org\/10.1093\/INTIMM\/DXV113.","journal-title":"Int Immunol"},{"key":"790_CR40","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/IAI.00936-15","volume":"83","author":"F Torres-Juarez","year":"2015","unstructured":"Torres-Juarez F, Cardenas-Vargas A, Montoya-Rosales A, Gonz\u00e1lez-Curiel I, Garcia-Hernandez MH, Enciso-Moreno JA, et al. LL-37 Immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages. Infect Immun. 2015;83:4495. https:\/\/doi.org\/10.1128\/IAI.00936-15.","journal-title":"Infect Immun"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:01:39Z","timestamp":1764115299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00790-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}},{"value":"All procedures involving animals were in compliance with the European Community Council Directive of 24 November 1986, and ethical approval was granted by the Local Ethical Committee for Animal Research at the Medical University of Lodz with the following number: 33\/\u0141B145\/2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}